Detalhe da pesquisa
1.
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial.
EuroIntervention
; 19(4): e323-e329, 2023 Jul 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37306039
2.
Inflammation as a Prognostic Marker in Heart Failure.
Cureus
; 14(8): e28605, 2022 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-36185864
3.
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial
EuroIntervention
; 19(4): E323-E329, jul.2023.
Artigo
Inglês
| CONASS, SES-SP, SES SP - Instituto Dante Pazzanese de Cardiologia, SES-SP | ID: biblio-1444455